Pacira Biosciences shareholder Doma Perpetual Capital Management nominated three candidates to Pacira's board of directors, alleging it isn't doing enough to return profits to shareholders.
DOMA Perpetual Capital beneficially owns approximately 4.2% of the outstanding shares of common stock of Pacira (PCRX) BioSciences. DOMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback